Lyme IggigmIgmab Results

Human Centriole and Centrosome Antibody IgG ELISA Kit

MBS039049-10x96StripWells 10x96-Strip-Wells
EUR 6725

Human IgG antibody Laboratories manufactures the lyme iggigm/igmab results reagents distributed by Genprice. The Lyme Iggigm/Igmab Results reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Lyme products are available in stock. Specificity: Lyme Category: Iggigm/Igmab Group: Results

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

96T
EUR 700
Description: ELISA

Human True Insulin ELISA Kit

10x96-Strip-Wells
EUR 6725

Human True Insulin ELISA Kit

48-Strip-Wells
EUR 550

Human True Insulin ELISA Kit

5x96-Strip-Wells
EUR 3420

Human True Insulin ELISA Kit

96-Strip-Wells
EUR 765

Human True Insulin GENLISA ELISA

1 x 96 wells
EUR 286

Results information

TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk

AE-320880-RDT-25 1 pk
EUR 351.6

TruStrip RDT Cow/Bovine Infectious rhinitis (IBR) antibody rapid test card, results is 2-10 mins, 50 cards/pk

RV-500300-RDT 1 pk Ask for price

TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk

RV-501200-RDT 1 pk Ask for price

TruStrip RDT Human Anti-Zaire Ebola virus glycoprotein (GP) antibody rapid test (visual results in 2-10 min), 10 cassettes/pk

AE-320625-RDT 1 pk
EUR 351.6

Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores

BR20838 row: 13; column: 16; cores: 208; cases: 118
EUR 474
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case

Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

BR20824 row: 13; column: 16; cores: 208; cases: 104
EUR 474
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case

Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores

BRC051 row: 1; column: 5; cores: 5; cases: 5
EUR 42
Description: Breast invasive carcinoma of no special type microarray, containing 4 casee of breast invasive carcinoma of no special type and 1 normal breast tissue, single core per case

Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores

FMG010 row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a

BR1201b row: 10; column: 12; cores: 120; cases: 60
EUR 354
Description: Breast carcinoma tissue microarray (most of triple negative), containing 56 cases invasive carcinoma of no special type, 2 cases invasive papillary adenocarcinoma, 1 each of medullary carcinoma and apocrine carcinoma, duplicate core per case

Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores

BR1510 row: 10; column: 15; cores: 150; cases: 50
EUR 354
Description: Breast carcinoma tissue microarray, containing 45 cases of invasive carcinoma of no special type, 2 medullary carcinoma, 1 each of metaplastic carcinoma, mixed carcinoma and apocrine carcinoma, triplicate cores per case

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d

FMG08013e row: 8; column: 9; cores: 72; cases: 72
EUR 168
Description: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case

Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b

HER2c row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case

Lyme Borrelia IgG

GWB-3603E0 1x96 Assays Ask for price

Human Lyme IgG ELISA Kit

201-12-1818 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Lyme IgG ELISA Kit

GA-E1834HM-48T 48T
EUR 346.8

Human Lyme IgG ELISA Kit

GA-E1834HM-48Tests 48 Tests Ask for price

Human Lyme IgG ELISA Kit

GA-E1834HM-96T 96T
EUR 559.2